Home › alpha-Mannosidosis
alpha-Mannosidosis clinical trials recruiting in the U.S.
5 studies for alpha-Mannosidosis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
RecruitingPhase 1
1 Week – 22 Years · All sexes · Updated Sep 3, 2026 · NCT02254863Longitudinal Study of Neurodegenerative Disorders
RecruitingObservational study
All ages · All sexes · Updated Feb 9, 2026 · NCT03333200Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
RecruitingObservational study
2 Months – 60 Years · All sexes · Updated Jan 13, 2026 · NCT04528355Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
RecruitingPhase 2
2 Months – 55 Years · All sexes · Updated Dec 15, 2025 · NCT01962415Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3
RecruitingObservational study
Up to age 3 · All sexes · Updated May 16, 2025 · NCT06184503From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.